DUBLIN, Oct. 29, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/b58s7h/global_hiv_drugs) has announced the addition of the "Global HIV Drugs Market 2015-2019" report to their offering.
The global HIV drugs market to grow at a CAGR of 4.52% over the period 2014-2019.
The report, Global HIV Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
This report covers the present scenario and the growth prospects of the global HIV drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various generic and branded drugs and the expected launch of drug candidates used in the treatment of HIV infection.
Strategic alliances formed between companies, in terms of licensing and collaboration, is a key market trend that is helping co-development and commercialization of drugs in different regions.
According to the report, unmet medical needs in the market present significant growth opportunities for vendors.
Further, the report states that adverse effects such as hepatotoxicity, hyperglycemia, hyperlipidemia, lactic acidosis, lipodystrophy, osteonecrosis, osteopenia, osteoporosis, and skin rash presents a significant challenge to this market.
Based on the class of drugs, the market is segmented as follows:
- Multi-class combination products
- Nucleoside reverse transcriptase inhibitors
- Non-nucleoside reverse transcriptase inhibitors
- Protease inhibitors
- Fusion inhibitors
- Entry inhibitors - CCR5 co-receptor antagonist
- HIV integrase strand transfer inhibitors
- Bristol-Myers Squibb
- Gilead Sciences
- Johnson & Johnson
Other prominent vendors
- Boehringer Ingelheim
- Daiichi Sankyo
- F. Hoffmann-La Roche
- Hetero Drugs
- Teva Pharmaceutical Industries
For more information visit http://www.researchandmarkets.com/research/b58s7h/global_hiv_drugs
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets